Prehospital Antibiotics Against Sepsis Trial

NACompletedINTERVENTIONAL
Enrollment

2,672

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
SepsisSevere SepsisSeptic Shock
Interventions
DRUG

Ceftriaxone 2000 mg

Ceftriaxone 2000 mg

Trial Locations (34)

1186 AM

Amstelland Ziekenhuis, Amstelveen

Unknown

Meander Medical Center, Amersfoort

Academic Medical Centre, Amsterdam

BovenIJ hospital, Amsterdam

Onze Lieve Vrouwe Gasthuis Oost (former: St. Lucas Andreas Hospital), Amsterdam

Onze Lieve Vrouwe Gasthuis Oost, Amsterdam

VU medical center, Amsterdam

Rijnstate Hospital, Arnhem

Rode Kruis Hospital, Beverwijk

Amphia Hospital, Breda

Albert Schweitzer Hospital, Dordrecht

Gelderse Vallei, Ede

Catharina Hospital, Eindhoven

Maxima Medical Center, Eindhoven

St.Anna Hospital, Geldrop

Zuyderland Hospital, Geleen

Beatrix Hospital, Gorinchem

Spaarne Gasthuis, Haarlem, Haarlem

Zuyderland Hospital, Heerlen

Elkerliek Hospital, Helmond

Spaarne Gasthuis, Hoofddorp

Maastricht Medical Center, Maastricht

St.Antonius Hospital, Nieuwegein

Canisius Wilhemina Hospital, Nijmegen

Bravis Hospital, Roosendaal

Haven Hospital, Rotterdam

Ikazia Hospital, Rotterdam

Maasstad Hospital, Rotterdam

St.Franciscus Gasthuis, Rotterdam

Vlietland Hospital, Schiedam

Rivierenland Hospital, Tiel

Diakonesse Hospital, Utrecht

University Medical Center, Utrecht, Utrecht

VieCuri Medical Center, Venlo

All Listed Sponsors
collaborator

Stichting Nuts Ohra

OTHER

collaborator

Nederlandse Internisten Vereniging ( Dutch Association of Internists)

UNKNOWN

lead

Amsterdam UMC, location VUmc

OTHER

NCT01988428 - Prehospital Antibiotics Against Sepsis Trial | Biotech Hunter | Biotech Hunter